Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.
The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.
ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.

According to this study, over the next five years the Gene Therapies for Cancer Treatment market will register a 67.3% CAGR in terms of revenue, the global market size will reach US$ 25300 million by 2024, from US$ 1940 million in 2019. In particular, this report presents the global revenue market share of key companies in Gene Therapies for Cancer Treatment business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Gene Therapies for Cancer Treatment market by product type, application, key companies and key regions.

This study considers the Gene Therapies for Cancer Treatment value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.
Gene Induced Immunotherapy
Oncolytic Virotherapy
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.
Hospital
Clinic
Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Gene Therapies for Cancer Treatment market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gene Therapies for Cancer Treatment market by identifying its various subsegments.
Focuses on the key global Gene Therapies for Cancer Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Therapies for Cancer Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the size of Gene Therapies for Cancer Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.